Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
-60.14%
-60.99%
-147.69%
283.13%
81.38%
48.43%
34.42%
ROA
-53.68%
-50.1%
-60.29%
-67.26%
-69.94%
-70.62%
-71.02%
Gross Margin
62.44%
56.39%
56.39%
56.39%
56.39%
56.39%
56.39%
Sector average
-
17.71%
17.71%
17.71%
17.71%
17.71%
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Clinical Laserthermia Systems AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
62.35%
Net Margin
-237.96%
-301.3%
-300.2%
-300.2%
-300.2%
-300.2%
-300.2%
Total Assets
SEK 76,486.00K
SEK 66,566.00K
SEK 68,253.25K
SEK 77,538.61K
SEK 86,598.00K
SEK 93,003.52K
SEK 97,440.31K
Sector average
-
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
SEK 1,806,991.80K
Net Income
-SEK 41,612.00K
-SEK 35,832.67K
-SEK 40,640.30K
-SEK 49,027.72K
-SEK 57,396.04K
-SEK 63,414.02K
-SEK 67,624.08K
Sector average
-
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
-SEK 13,704.11K
Valuation
-
SEK 333,812.38K
SEK 378,599.66K
SEK 456,735.66K
SEK 534,693.87K
SEK 590,756.57K
SEK 629,976.92K
Sector average
-
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
SEK 3,179,755.44K
Stock Price
-
SEK 6.88
SEK 7.80
SEK 9.41
SEK 11.02
SEK 12.18
SEK 12.98
Sector average
-
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
SEK 36.70
Clinical Laserthermia Systems AB (publ) (CLS-B.ST) Financial Forecast | Equlion
